Image 01 (Ebd84428 E4bd 415b Af5d 5832506b0e38 01)
Dapagliflozin And Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 70748-101
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Dapagliflozin And Metformin Hydrochloride (NDC 70748-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02 (Ebd84428 E4bd 415b Af5d 5832506b0e38 02)
03 (Ebd84428 E4bd 415b Af5d 5832506b0e38 03)
This is a chart showing the relationship between CFB in 24-Hour Urinary Glucose (g) and Dapagliflozin Dose (mg). It includes observed values for healthy subjects and subjects with T2DM, along with fitted lines for both groups. The chart ranges from 0.001 to 1.0 g for urinary glucose and 0 to 1000 mg for dapagliflozin dose.*
Image 04 (Ebd84428 E4bd 415b Af5d 5832506b0e38 04)
Figure 3 (Ebd84428 E4bd 415b Af5d 5832506b0e38 05)
Figure 4: Time To First Occurrence Of Hospitalization For Heart Failure Or Cv Death In The Declare Study (Ebd84428 E4bd 415b Af5d 5832506b0e38 06)
Not available.*
Figure 5: Time To First Occurrence Of Hospitalization For Heart Failure In The Declare Study (Ebd84428 E4bd 415b Af5d 5832506b0e38 07)
Figure 7: Time To First Occurrence Of The Primary Composite Endpoint, ≥50% Sustaineddecline In Egfr, Eskd, Cv Or Renal Death (dapa-ckd Study) (Ebd84428 E4bd 415b Af5d 5832506b0e38 08)
Figure 6: Time To The First Occurrence Of The Composite Of Cardiovascular Death, Hospitalization For Heart Failure Or Urgent Heart Failure Visit In The Dapa-hf Study (Ebd84428 E4bd 415b Af5d 5832506b0e38 09)
B) Deliver (Ebd84428 E4bd 415b Af5d 5832506b0e38 10)
Figure 8 (Ebd84428 E4bd 415b Af5d 5832506b0e38 11)
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 12)
This text provides information about a medication containing 5 mg dapagliflozin and 500 mg metformin hydrochloride in each tablet. It includes instructions for dispensing the medication guide to each patient, dosage details, storage conditions, and a reminder not to use the product if the inner seal is broken or missing. The tablets should not be crushed, cut, or chewed, and must be swallowed whole. The product is manufactured by Lupin Limited in India for Lupin Pharmaceuticals, Inc. in the United States.*
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 13)
The text provides details about a medication containing 5 mg of dapagliflozin and 1000 mg of metformin hydrochloride, manufactured for Lupin Pharmaceuticals, Inc. It includes the usual dosage information and storage instructions, as well as a reminder not to use if the inner seal is broken. The tablets should not be crushed, cut, or chewed but swallowed whole. The medication guide should be dispensed separately to each patient.*
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 14)
The text provides information about a medication called NocToTaB 10306 with a dosage of 10 mg/500 mg. It instructs the pharmacist to dispense the medication guide separately to each patient. The storage conditions are to be kept at or below 25°C. The tablets should not be crushed, cut, or chewed, and must be swallowed whole. This medication is in tablet form, with the packaging mentioning LUPIN® 30 Tablets. Overall, it is important to follow the instructions provided for proper use and storage of NocToTaB 10306.*
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 15)
This is a medication information label with details including NDC code, dosage information, manufacturer, storage instructions, and a warning not to crush, cut, or chew tablets. It is important for the pharmacist to dispense the medication guide separately to each patient.*
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 160 1)
Image (Ebd84428 E4bd 415b Af5d 5832506b0e38 283 2)
This is a statement indicating that "LUPIN" and the symbol "%" are registered trademarks belonging to Lupin Pharmaceuticals, Inc. These trademarks are protected intellectual property of the company.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
